209 related articles for article (PubMed ID: 30685548)
1. Modeling PpIX effective light fluence at depths into the skin for PDT dose comparison.
LaRochelle EPM; Marra K; LeBlanc RE; Chapman MS; Maytin EV; Pogue BW
Photodiagnosis Photodyn Ther; 2019 Mar; 25():425-435. PubMed ID: 30685548
[TBL] [Abstract][Full Text] [Related]
2. Effective fluence and dose at skin depth of daylight and lamp sources for PpIX-based photodynamic therapy.
Ruiz AJ; LaRochelle EPM; Samkoe KS; Chapman MS; Pogue BW
Photodiagnosis Photodyn Ther; 2023 Mar; 41():103260. PubMed ID: 36627070
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Blue and White Lamp Light with Sunlight for Daylight-Mediated, 5-ALA Photodynamic Therapy, in vivo.
Marra K; LaRochelle EP; Chapman MS; Hoopes PJ; Lukovits K; Maytin EV; Hasan T; Pogue BW
Photochem Photobiol; 2018 Sep; 94(5):1049-1057. PubMed ID: 29663426
[TBL] [Abstract][Full Text] [Related]
4. A dynamic model for ALA-PDT of skin: simulation of temporal and spatial distributions of ground-state oxygen, photosensitizer and singlet oxygen.
Liu B; Farrell TJ; Patterson MS
Phys Med Biol; 2010 Oct; 55(19):5913-32. PubMed ID: 20844331
[TBL] [Abstract][Full Text] [Related]
5. Quantifying the radiant exposure and effective dose in patients treated for actinic keratoses with topical photodynamic therapy using daylight and LED white light.
Manley M; Collins P; Gray L; O'Gorman S; McCavana J
Phys Med Biol; 2018 Jan; 63(3):035013. PubMed ID: 29192611
[TBL] [Abstract][Full Text] [Related]
6. Weather conditions and daylight-mediated photodynamic therapy: protoporphyrin IX-weighted daylight doses measured in six geographical locations.
Wiegell SR; Fabricius S; Heydenreich J; Enk CD; Rosso S; Bäumler W; Baldursson BT; Wulf HC
Br J Dermatol; 2013 Jan; 168(1):186-91. PubMed ID: 22860885
[TBL] [Abstract][Full Text] [Related]
7. The influence of different illumination parameters on protoporphyrin IX induced cell death in squamous cell carcinoma cells.
Novak B; Heesen L; Schary N; Lübbert H
Photodiagnosis Photodyn Ther; 2018 Mar; 21():385-392. PubMed ID: 29427796
[TBL] [Abstract][Full Text] [Related]
8. A quantitative assessment of protoporphyrin IX metabolism and phototoxicity in human skin following dose-controlled delivery of the prodrugs 5-aminolaevulinic acid and 5-aminolaevulinic acid-n-pentylester.
Gerscher S; Connelly JP; Beijersbergen Van Henegouwen GM; MacRobert AJ; Watt P; Rhodes LE
Br J Dermatol; 2001 May; 144(5):983-90. PubMed ID: 11359385
[TBL] [Abstract][Full Text] [Related]
9. Assessing daylight & low-dose rate photodynamic therapy efficacy, using biomarkers of photophysical, biochemical and biological damage metrics in situ.
de Souza ALR; LaRochelle E; Marra K; Gunn J; Davis SC; Samkoe KS; Chapman MS; Maytin EV; Hasan T; Pogue BW
Photodiagnosis Photodyn Ther; 2017 Dec; 20():227-233. PubMed ID: 29037911
[TBL] [Abstract][Full Text] [Related]
10. Improving in vitro photodynamic therapy through the development of a novel iron chelating aminolaevulinic acid prodrug.
Curnow A; Perry A; Wood M
Photodiagnosis Photodyn Ther; 2019 Mar; 25():157-165. PubMed ID: 30553949
[TBL] [Abstract][Full Text] [Related]
11. Relationship of protoporphyrin IX synthesis to photodynamic effects by 5-aminolaevulinic acid and its esters on various cell lines derived from the skin.
Lee JB; Choi JY; Chun JS; Yun SJ; Lee SC; Oh J; Park HR
Br J Dermatol; 2008 Jul; 159(1):61-7. PubMed ID: 18489589
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 10 efficient protocols for photodynamic therapy of actinic keratosis: How relevant are effective light dose and local damage in predicting the complete response rate at 3 months?
Vignion-Dewalle AS; Baert G; Thecua E; Lecomte F; Vicentini C; Abi-Rached H; Mortier L; Mordon S
Lasers Surg Med; 2018 Jul; 50(5):576-589. PubMed ID: 29667728
[TBL] [Abstract][Full Text] [Related]
13. Pre-treatment protoporphyrin IX concentration in actinic keratosis lesions may be a predictive biomarker of response to aminolevulinic-acid based photodynamic therapy.
Kanick SC; Davis SC; Zhao Y; Sheehan KL; Hasan T; Maytin EV; Pogue BW; Chapman MS
Photodiagnosis Photodyn Ther; 2015 Dec; 12(4):561-6. PubMed ID: 26480810
[TBL] [Abstract][Full Text] [Related]
14. Continuous ultra-low-intensity artificial daylight is not as effective as red LED light in photodynamic therapy of multiple actinic keratoses.
Wiegell SR; Heydenreich J; Fabricius S; Wulf HC
Photodermatol Photoimmunol Photomed; 2011 Dec; 27(6):280-5. PubMed ID: 22092730
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic Therapy Effectively Treats Actinic Keratoses Without Pre-Illumination Incubation Time.
Gandy J; Labadie B; Bierman D; Zachary C
J Drugs Dermatol; 2017 Mar; 16(3):275-278. PubMed ID: 28301624
[TBL] [Abstract][Full Text] [Related]
16. The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin.
Middelburg TA; de Bruijn HS; van der Ploeg-van den Heuvel A; Neumann HA; Robinson DJ
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):703-9. PubMed ID: 24284130
[TBL] [Abstract][Full Text] [Related]
17. Development of a handheld fluorescence imaging device to investigate the characteristics of protoporphyrin IX fluorescence in healthy and diseased skin.
Kulyk O; Ibbotson SH; Moseley H; Valentine RM; Samuel ID
Photodiagnosis Photodyn Ther; 2015 Dec; 12(4):630-9. PubMed ID: 26467274
[TBL] [Abstract][Full Text] [Related]
18. Targeting of sebaceous glands by δ-aminolevulinic acid-based photodynamic therapy: An in vivo study.
Kosaka S; Miyoshi N; Akilov OE; Hasan T; Kawana S
Lasers Surg Med; 2011 Jul; 43(5):376-81. PubMed ID: 21674542
[TBL] [Abstract][Full Text] [Related]
19. In vitro/in vivo correlations between transdermal delivery of 5-aminolaevulinic acid and cutaneous protoporphyrin IX accumulation and effect of formulation.
Tsai JC; Chen IH; Wong TW; Lo YL
Br J Dermatol; 2002 May; 146(5):853-62. PubMed ID: 12000384
[TBL] [Abstract][Full Text] [Related]
20. Monte Carlo modeling of in vivo protoporphyrin IX fluorescence and singlet oxygen production during photodynamic therapy for patients presenting with superficial basal cell carcinomas.
Valentine RM; Brown CT; Moseley H; Ibbotson S; Wood K
J Biomed Opt; 2011 Apr; 16(4):048002. PubMed ID: 21529097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
